Medical News

RSS

Sutter Health collaborates with iTriage

Consumers can check health symptoms, look up health conditions and now find detailed information about doctors, hospitals, emergency rooms and medical clinics in the Sutter Health network via the free mobile health care application – iTriage.

31 Aug 2010

Salix Pharmaceuticals to settle patent litigation of Novel's generic version of MOVIPREP

Salix Pharmaceuticals, Ltd. today announced that Salix and Norgine B. V. have entered into an agreement with Novel Laboratories, Inc. to settle patent litigation currently pending in the U.S. District Court for the District of New Jersey (Civil Action No. 3:08-02311 (FLW)(TJB)) regarding Novel's proposed generic version of MOVIPREP.

31 Aug 2010

First UK PyroTITAN Humeral Resurfacing Implant performed at BMI - The Alexandra Hospital

Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic devices, announces the implantation of the first PyroTITAN™ Humeral Resurfacing Implant in the United Kingdom. The PyroTITAN was implanted at BMI - The Alexandra Hospital in Cheadle, Cheshire.

31 Aug 2010

Tapentadol ER improves average intensity of chronic osteoarthritis knee pain: Study

Phase 3 safety and efficacy data comparing tapentadol extended release (ER) tablets, an investigational pain medication, to placebo in patients with moderate to severe chronic osteoarthritis knee pain have been published by Clinical Drug Investigation.

31 Aug 2010

Roche's MabThera continues to dwarf recently launched monoclonal antibodies: Report

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of non-Hodgkin's lymphoma and chronic lymphocytic leukemia, 41 percent of surveyed European hematologist-oncologists say that the favorable efficacy profile of Roche's MabThera (rituximab) is the most significant driver of their use of this brand, while 26 percent say MabThera's favorable risk-benefit profile is the most significant driver.

31 Aug 2010

Uninsured Maine adults with mental illness struggle to get care; Florida continues to push to repeal reform

Kennebec (Maine) Journal: "A growing number of uninsured Mainers with mental illness are falling through the cracks of the health care system because of state budget cuts and financial strains on nonprofits, according to state officials and private agencies. Just as when someone goes without treatment for a toothache and ends up in the ER, the lack of access to regular mental health care means illnesses are getting more expensive and patients are getting sicker, officials said."

31 Aug 2010

Forensic Fluids Laboratories ranked #167th on Inc. 500 fastest growing companies list

Forensic Fluids Laboratories Inc., a leading provider of oral fluid drug testing, today announced that the company was named to the prestigious Inc. 500 list, a list of the most entrepreneurial and fastest growing companies in the United States. Forensic Fluids Lab was number 167 on the general list, number 10 in health care, number 2 in Michigan, and number 20 for women-owned.

31 Aug 2010

Valley Presbyterian Hospital wins 'Best Hospital' designation for fifth consecutive year

Valley Presbyterian Hospital (VPH) has won the "Best Hospital" designation for the fifth consecutive year in a poll of Los Angeles Daily News readers. The annual Readers' Choice online survey was conducted independently by the Los Angeles Daily News.

31 Aug 2010

Liberal health reform group pushing hard to save lawmakers, Berwick won't disclose donors

Politico: The liberal health group Health Care for America Now is "fighting hard to help reelect lawmakers who voted for the [health reform] bill — even if it means not talking about it. … HCAN activists say they are not dodging their key issue; rather, they want to keep pace with voter concerns, which have markedly shifted over the past year.

31 Aug 2010

Achaogen receives contract from BARDA for developing ACHN-490 antibiotic treatment

Achaogen, a biopharmaceutical company discovering and developing innovative antibiotics to treat life-threatening, multi-drug resistant (MDR) bacterial infections, today announced the award of a contract with The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services.

31 Aug 2010

AOD Software named to 2010 Inc. 5000 list of fastest-growing private companies

Inc. magazine ranked AOD Software on its annual Inc. 5000, an exclusive ranking of the nation's fastest-growing private companies. The list represents the most comprehensive look at the most important segment of the economy — America's independent-minded entrepreneurs. AOD Software was ranked as number 219 across the Software companies in the country.

31 Aug 2010

FDA grants Priority Review status to Alimera Sciences' Iluvien for diabetic macular edema

Alimera Sciences, Inc.,, a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that the Company's New Drug Application (NDA) for Iluvien® (fluocinolone acetonide intravitreal insert) has been accepted for filing and granted Priority Review status by the U.S. Food and Drug Administration (FDA).

31 Aug 2010

VA's liabilities grow as agency expands list of diseases linked to Agent Orange

Politico looks at a new fight brewing over Agent Orange and how it affects programs for Vietnam Veterans. "It's a world turned upside-down from decades ago when returning soldiers had to fight to get attention for deadly lymphomas linked to the herbicide. Now the frailties of men in their 60s — prostate cancer, diabetes, heart disease — lead the list of qualified Agent Orange disabilities, and the result has been an explosion in claims — and the government's liability.

31 Aug 2010

FDA extends Prescription Drug User Fee Act date for ezogabine

GlaxoSmithKline and Valeant Pharmaceuticals International announced today the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for ezogabine to 30 November 2010.

31 Aug 2010

Intendis granted rights to KYTHERA's ATX-101 candidate for minimally-invasive fat reduction outside US, Canada

KYTHERA Biopharmaceuticals, Inc. and Intendis, Bayer HealthCare's dermatology business, today announced that they have entered into a licensing agreement granting Intendis rights to KYTHERA's lead product candidate, ATX-101, outside of the US and Canada. ATX-101, a first-in-class investigational drug, is currently in clinical development for the reduction of localized fat under the chin (submental fat).

31 Aug 2010

Medicare beneficiaries receive prescription drug cost relief under Affordable Care Act

U.S. Department of Health and Human Services Secretary Kathleen Sebelius today announced that more than 1 million Medicare beneficiaries have received prescription drug cost relief through the Affordable Care Act.

31 Aug 2010

Elan Corporation offers to purchase Senior Fixed Rate Notes due 2013

Elan Corporation, plc announced today that Elan's wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp., commenced an offer to purchase of up to $186,000,000 aggregate principal amount of their 8 7/8% Senior Fixed Rate Notes due 2013 (the "2013 Fixed Rate Notes") and their Floating Rate Notes Due 2013 (the "2013 Floating Rate Notes" together with the 2013 Fixed Rate Notes, the "2013 Notes"),

31 Aug 2010

Bionovo announces reverse stock split to maintain NASDAQ Capital Market common stock

Bionovo, Inc. announced today that it will effect a 1-for-5 reverse stock split, that will become effective with the opening of trading on August 31, 2010.

31 Aug 2010

Unilife Corporation 2010 fourth quarter revenue increases to $2.7 million

Unilife Corporation today announced preliminary financial results for the fourth quarter and fiscal year ended June 30, 2010.

31 Aug 2010

Origin Agritech 2010 third quarter revenue decreases to $68.07 million

Origin Agritech Limited, a technology focused supplier of crop seeds in China, today announced unaudited financial results for the third quarter ended June 30, 2010. Origin prepares its financial statements in accordance with generally accepted accounting principles (GAAP) of the United States.

31 Aug 2010

Medical News

Sutter Health collaborates with iTriage

Salix Pharmaceuticals to settle patent litigation of Novel's generic version of MOVIPREP

First UK PyroTITAN Humeral Resurfacing Implant performed at BMI - The Alexandra Hospital

Tapentadol ER improves average intensity of chronic osteoarthritis knee pain: Study

Roche's MabThera continues to dwarf recently launched monoclonal antibodies: Report

Uninsured Maine adults with mental illness struggle to get care; Florida continues to push to repeal reform

Forensic Fluids Laboratories ranked #167th on Inc. 500 fastest growing companies list

Valley Presbyterian Hospital wins 'Best Hospital' designation for fifth consecutive year

Liberal health reform group pushing hard to save lawmakers, Berwick won't disclose donors

Achaogen receives contract from BARDA for developing ACHN-490 antibiotic treatment

AOD Software named to 2010 Inc. 5000 list of fastest-growing private companies

FDA grants Priority Review status to Alimera Sciences' Iluvien for diabetic macular edema

VA's liabilities grow as agency expands list of diseases linked to Agent Orange

FDA extends Prescription Drug User Fee Act date for ezogabine

Intendis granted rights to KYTHERA's ATX-101 candidate for minimally-invasive fat reduction outside US, Canada

Medicare beneficiaries receive prescription drug cost relief under Affordable Care Act

Elan Corporation offers to purchase Senior Fixed Rate Notes due 2013

Bionovo announces reverse stock split to maintain NASDAQ Capital Market common stock

Unilife Corporation 2010 fourth quarter revenue increases to $2.7 million

Origin Agritech 2010 third quarter revenue decreases to $68.07 million

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News